Hydroxy Compound Active Ingredients TRIZ Cases
- D-Cycloserine Antagonist Reduces Psychiatric Side Effects
D-cycloserine acts as a competitive NMDAR antagonist to mitigate anxiety and akathisia caused by antipsychotic medications.
- Cannabinoid Tablet Compression Without Excipients
Direct compression of pure cannabidiol into tablets by controlling particle size and moisture content, eliminating flow agents that compromise purity.
- Cannabinoid Carotenoid Supplementation for Skin Repair
A supplement formulation combines cannabinoids, carotenoids, and hyaluronic acid to enhance transdermal absorption.
- MLPSC Therapy for Cerebral Infarction Recovery
STRO-1+ stem cells migrate to infarcted brain regions via paracrine signaling, reducing lesion volume and improving functional recovery.
- Topical Muscle Recovery Composition via Adhesive Bandage Pod
Adhesive bandage pod applies topical workout muscle recovery composition to specific muscles, avoiding whole-body distribution from oral supplements.
- Two-Chamber Infusion Preparation Managing Potassium and Osmotic Pressure
Segmenting the formulation prevents Maillard reactions and hyperkalemia risk while allowing stable vitamin incorporation in a simplified device.
- Clofoctol Repurposing for Glioma Stem Cell Inhibition
Clofoctol targets glioma stem cells to reduce tumor formation, addressing neuroglioma recurrence and drug resistance.
- Statin-Cannabinoid Compositions for Reduced Muscle Toxicity
Combining statins with cannabinoids enhances bioavailability to lower effective doses while mitigating muscle problems and adverse effects.
- Nrf2 Activators Enhance NK and T Cell Survival in Cancer Therapy
Pre-treating NK and T cells with Nrf2 activators counters tumor microenvironment suppression, improving adoptive cell therapy efficacy.
- Methanol Prodrugs for Sustained Formate Release in Immunotherapy
Methanol prodrugs provide sustained formate release to support immune cell survival, avoiding rapid elimination and toxicity from direct administration.